Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Stomach Neoplasms 106Pancreatic Neoplasms 31Esophageal Neoplasms 17Esophageal Squamous Cell Carcinoma 11Biliary Tract Neoplasms 11Colorectal Neoplasms 10Cholangiocarcinoma 7Neoplasm Metastasis 5Nasopharyngeal Carcinoma 5Adenocarcinoma 5Recurrence 4Head and Neck Neoplasms 4Gastrointestinal Neoplasms 4Colonic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Rectal Neoplasms 3Gallbladder Neoplasms 3Advanced Pancreatic Cancer 3Advanced Gastric Cancer 3Stage IV Gastric Cancer With Metastasis 2Neoplasms 2NSCLC 2Locally Advanced Gastric Cancer 2Gastric Cancer Peritoneal Metastases 2Gastric Adenocarcinoma 2Carcinoma, Hepatocellular 2Breast Neoplasms 2mCRC 1Surgically-Created Resection Cavity 1Squamous Cell Carcinoma of Head and Neck 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Capecitabine 222Letrozole 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 133Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × S 1 (combination) × Clear all
NCT00438100 2015-05-29

Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer

Japan Breast Cancer Research Network

Phase 2 Completed
142 enrolled 4 charts
Breast

Breast Neoplasms

NCT01849380 2013-05-08

Neoadjuvant ECS Versus ECF in Local Advanced Breast Cancer

Shandong University

Phase 4 Unknown
240 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡